CardioDx

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, CardioDx is committed to expanding patient access and improving healthcare quality and efficiency through the commercialization of genomic technologies.
Type
Private
HQ
Redwood City, US
Founded
2004
Employees
146 (est)
CardioDx was founded in 2004 and is headquartered in Redwood City, US

Key People at CardioDx

David Levison

David Levison

Founder & President & CEO
Andrew Guggenhime

Andrew Guggenhime

CFO
David Chernoff

David Chernoff

Chief Medical Officer
Susan Daniels

Susan Daniels

VP, Development
Gwen Carscadden

Gwen Carscadden

VP, Human Resources
Deborah L. Kilpatrick

Deborah L. Kilpatrick

Chief Commercial Officer

CardioDx Locations

Redwood City, US
Greensboro, US

CardioDx Metrics

CardioDx Summary

Founding Date

2004

Total Funding

$284 M

Latest funding size

$12.4 M

Time since last funding

11 months

Investors

We estimate that CardioDx's latest funding round in February 2016 was $12.4 M. In total, CardioDx has raised $284 M

CardioDx Online Presence

CardioDx Company Life

You may also be interested in